Vericel Corporation
USD43.86
-1.21 (-2.68%)
CEO
Dominick C. Colangelo
IPO Date
1997-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$45.32
Prev. Close
$45.07
Day Low
$43.59
Day High
$45.44
52W Low
$28.95
52W High
$46.62
Market Cap
$2.24B
Volume
0.13M
| 258.9 |
| 31 Dec 2023 | FY | 68.6% | -1.6% | -1.4% | -0.9% | 0.39 | 4.49 | -532.6 |
| 31 Dec 2022 | FY | 66.8% | -10.2% | -8.7% | -6.1% | 0.25 | 4.99 | -74.3 |
| 31 Dec 2021 | FY | 67.9% | -4.8% | -4.4% | -3.1% | 0.29 | 6.08 | -244.5 |
| 31 Dec 2020 | FY | 67.8% | 2.3% | 2.1% | 1.4% | 0.40 | 5.50 | 487.6 |
| 31 Dec 2019 | FY | 68.1% | -8.2% | -8.7% | -6.3% | 0.25 | 5.64 | -79.5 |
| 31 Dec 2018 | FY | 64.6% | -9.0% | -8.0% | -6.9% | 0.00 | 7.62 | -86.1 |
| 31 Dec 2017 | FY | 52.5% | -27.0% | -76.7% | -31.7% | 0.76 | 3.86 | -10.5 |
| 31 Dec 2016 | FY | 47.9% | -36.0% | -79.2% | -40.3% | 0.41 | 3.48 | -3.5 |
| 19.6 |
| 30 Sept 2025 | Q3 | 73.5% | 7.5% | 1.6% | 1.1% | 0.30 | 4.87 | 78.3 |
| 30 Jun 2025 | Q2 | 73.7% | -0.9% | -0.2% | -0.1% | 0.33 | 4.97 | -968.9 |
| 31 Mar 2025 | Q1 | 69.0% | -21.4% | -3.8% | -2.6% | 0.33 | 5.01 | -49.5 |
| 31 Dec 2024 | Q4 | 77.6% | 26.3% | 6.8% | 4.6% | 0.34 | 4.23 | 34.3 |
| 30 Sept 2024 | Q3 | 71.9% | -1.6% | -0.3% | -0.2% | 0.38 | 4.61 | -575.4 |
| 30 Jun 2024 | Q2 | 69.5% | -8.9% | -1.9% | -1.2% | 0.39 | 4.50 | -117.1 |
| 31 Mar 2024 | Q1 | 68.9% | -7.5% | -1.7% | -1.1% | 0.39 | 5.20 | -164.9 |
| 31 Dec 2023 | Q4 | 74.6% | 20.0% | 5.8% | 3.7% | 0.39 | 4.49 | 32.7 |